fda removing semaglutide crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many The FDA announced plans to

Sangvai also indicated administrative cuts ahead, including ending or reducing contracts, letting temporary employees go, and ending some quality control and compliance functions

It's common in planetary atmospheres to get cyclones near the poles

pediatric patients

Allergan Aesthetics is committed to equipping our customers with data-driven insights, education, and consultation tools to help guide patients safely and effectively through these changes, said Glen Curran, senior vice president at Allergan Aesthetics, in a release

If you already take a GLP-1 medication and have Afib or are at increased risk for it, this research shows that you may be getting an added heart health benefit beyond weight loss or blood sugar control

Novo Nordisk is expected to lose patent protection in countries home to 40 percent of the world's population, with generics anticipated in the coming months in China, Canada, Brazil, Turkey and South Africa [Source: nytimes.com/2026/03/19/health/ozempic-wegovy-generic-india-china-canada.html]